2024 Conferences
October 20 — 24, 2024
INTEGRATED CONTINUOUS BIOMANUFACTURING VI — 24AB
A. Azevedo, Instituto Superior Técnico; A. Noyes, Apogee Therapeutics; K. Brower, Sanofi
Leesburg, Virginia
2025 Conferences
April 27 – May 2, 2025
CELL CULTURE ENGINEERING XIX — 25AC
A. Khetan, BMS; M. Yu, Sutro Biopharma; M. Betenbaugh, Johns Hopkins University
Tucson, AZ
March 17 – 20, 2025
SINGLE-USE TECHNOLOGIES VII: REVOLUTIONIZING MANUFACTURING FOR TOMORROW’S MEDICINES — 25AU
N. Montenay, Sartorius; A. Rayat, University College London; A. DiBenedetto, Roche Genentech
Malta
March 30 – April 3, 2025
MICROBIAL ENGINEERING III: NEW GENERATION OF CELL FACTORY TO MEET THE FUTURE CHALLENGES AND TO SEIZE NEW OPPORTUNITIES — 25AM
E. Keshavarz-Moore, University College London; T. Sauer, Sanofi
Porto, Portugal
May 18 – 22, 2025
ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE AND SURGERY XVIII — 25AO
S. Gibbs, M. Skala and S. Andersson-Engels
Cork, Ireland
Summer 2025 TBA
ADVANCES IN COSMETIC FORMULATION DESIGN II— 20AY
S. Amin, Manhattan College; P. Somaundaran, Columbia University
Durham, NC
October 19-24, 2025
ENZYME ENGINEERING XXVIII — 25AE
J. Woodley, DTU; D. Hededam-Welner, DTU
Helsinger, Denmark
2026 Conferences
February 1-5 2026
ADVANCING MANUFACTURE OF CELL AND GENE THERAPIES IX — 26AT
J. Moscariello; C. Hoesli, McGill University; B. Marques, CenturyTC
Hilton Head, SC, USA
April 9-13, 2026
DELIVERY OF NUCLEIC ACID THERAPEUTICS III: BIOLOGY, ENGINEERING AND DEVELOPMENT — 26AC
L. Sepp-Lorenzino, Intellia Therapeutics; S. F. Dowdy, University of California San Diego School of Medicine; M. Stanton, Generational Bio
Croatia
Spring TBA
VACCINE TECHNOLOGY X — 26AA
T. Tagmyer, PATH; N. Alteras, Moderna; S. Frank, UCL; D. Cowley, AstaZeneca
Porto, Portugal
2026 TBA
BIOCHEMICAL AND MOLECULAR ENGINEERING XXIV — 26AM